Pioneering research ‘fundamentally changed’ our understanding of brain cancer and opened the door to new treatments.| UVA Health Newsroom
A new umbrella trial of molecularly driven therapies for high-grade gliomas (HGG) and diffuse intrinsic pontine glioma (DIPG) aims to improve quality of live and extend survival rates for these aggressive tumors.| Pediatrics Nationwide
Adding the chemotherapy pill temozolomide to radiation improves survival for adults with grade 2 gliomas, a clinical trial has found.| UVA Health Newsroom